EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension

Zhe Chen, Linhong Pang iD, Yidan Zheng, Li Xu, Mingjing Tang, Ziwen Zhao, Tianyu Wang, Jin Li, Yunfei Zhou, Lin Duo, Wenlong Zhu, Zhiling Luo iD und 2 weitere

Journal of Cardiovascular Development and Disease · 30.04.2026 · 13 (5) · 195

DOI: 10.3390/jcdd13050195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 30.04.2026. Verfasst von Zhe Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan …. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major science and technology special plan project of Yunnan Province, Yunnan Expert Workstation under the Yunnan Provincial Project for Scientific and Technological Talents and Platforms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Aim

The incidence of high-altitude pulmonary hypertension (HAPH) has risen in recent years and is expected to continue increasing; however, its diagnosis remains challenging. In this study, we employed proteomics and metabolomics to identify the proteins and metabolic biomarkers that contribute to the development of HAPH. (2)

Methods

We applied integrated proteomics and metabolomics to match blood samples from 40 HAPH patients and 40 healthy controls in Yunnan’s high-altitude regions to characterize molecular profiles, identify biomarkers, and develop a predictive model. (3)

Results

Proteomic analysis identified four proteins (A2IPH7, K1C14, PSME2, SERPINE2) commonly dysregulated in HAPH patients from two high-altitude regions. SERPINE2 was notably downregulated and showed a negative correlation with clinical severity, which was further validated in HAPH rat lung tissues and supported by UK Biobank data for idiopathic PAH. Concurrent metabolomics uncovered 11 shared metabolites, largely acyl fatty acids, enriched in pathways such as unsaturated fatty acid synthesis. Integration of these multi-omics data enabled the development of a robust predictive model. (4)

Conclusion

Our study identified key protein and metabolic biomarkers involved in HAPH development, which were validated in animal models. Based on these findings, a predictive model was developed, highlighting SERPINE2 and 11 metabolites as promising targets for the prediction and prevention of HAPH.

Schlagwörter

Stichwörter der Autor:innen

HAPHSERPINE2metabolomicproteomics

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, China.
  • Department of Structural Heart Center, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, 528 Shahebei Rd, Kunming 650102, China.
  • School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Department of Echocardiogram, Fuwai Yunnan Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming 650102, China.

ORCID-Profile: Linhong Pang, Zhiling Luo, Fei Li, Da Zhu

Förderung

  • National Natural Science Foundation of China
  • Major science and technology special plan project of Yunnan Province
  • Yunnan Expert Workstation under the Yunnan Provincial Project for Scientific and Technological Talents and Platforms

Zitieren

APA

Chen, Z., Pang, L., Zheng, Y., Xu, L., Tang, M., Zhao, Z., Wang, T., Li, J., Zhou, Y., Duo, L., Zhu, W., Luo, Z., Li, F., & Zhu, D. (2026). Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension. Journal of Cardiovascular Development and Disease, 13(5), 195. https://doi.org/10.3390/jcdd13050195

Vancouver

Chen Z, Pang L, Zheng Y, Xu L, Tang M, Zhao Z, et al. Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension. Journal of Cardiovascular Development and Disease. 2026;13(5):195. doi:10.3390/jcdd13050195

BibTeX
@article{Chen2026,
  author = {Chen, Zhe and Pang, Linhong and Zheng, Yidan and Xu, Li and Tang, Mingjing and Zhao, Ziwen and Wang, Tianyu and Li, Jin and Zhou, Yunfei and Duo, Lin and Zhu, Wenlong and Luo, Zhiling and Li, Fei and Zhu, Da},
  title = {Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {5},
  pages = {195},
  doi = {10.3390/jcdd13050195}
}
Kostenlos starten →